1 Siegel R,Ma J,Zou Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29. 2 Siegel R,Naishadham D,Jemal A.Cancer statistics[J].CA Cancer J Clin,2013,63(1):11-30. 3 中华医学会外科学分会胰腺外科学组.胰腺癌诊治指南(2014)[J].中华外科杂志,2014,52(12):881-887. 4 Jung Y,Lee S,Choi HS,et al.Clinical validation of colorectal cancer biomakers identified from bionformations analysis of public expression date[J].Clin Cancer Res,2011,17(4):700-709. 5 Sigal V,Singal AK,Kuo YF.Racial dispariries in treatment for pancreatic cancer and impact on survival:a population-based analysis[J].J Cancer Res Clin Oncol,2012,138(4):715-722. 6 张宏武,蒋升,徐焱成.新疆维吾尔族、哈萨克族和汉族糖尿病前期人群血清尿酸及代谢综合征分布的横断面研究[J].中华流行病学杂志,2013,34(10):958-960. 7 王育璠,赵立,顾鸣宇,等.胰腺癌与糖尿病关联的探讨[J].中国癌症杂志,2006,16(11):973-975. 8 Chang CK,Ulrich CM.Hyperinsulinacmia and hyperglycaemia:possible risk factors of colorectal cancer among diabetic patients[J].Diabctologia,2003,46(5):595-607. 9 Weber A,Kehl V,Mittermeyer T,et al.Prognostic factors for survival in patients with unresectable pancreatic cancer[J].Pancreas,2010,39(8):1247-1253. 10 展超,徐海涛,赵亮,等.胰十二指肠切除术后肠内与肠外营养支持的疗效研究[J].实用肿瘤学杂志,2012,26(3):225-226,258. 11 张群华,倪泉兴.代表中国抗癌协会胰腺癌专业委员会 胰腺癌2340例临床病例分析[J].中华医学杂志,2004,(3):214-218. 12 Lim JE,Chien MW,Earle CC,et al.Prognostic factors following curative resection for pancreatic adenocarcinoma:a population-based,linked database analysis of 396 patients[J].Ann Sur,2003,237(1):74-85. 13 Haeberle B,Schweinitz D.Treatment of heptoblastoma in the German cooperative pediatric liver tumor studies[J].Front Biosci(Elite Ed),2012,4:493-498. 14 梁宇闯,李卓永,林坚,等.介入栓塞治疗四肢肌间血管瘤的远期疗效[J].中国介入影像与治疗学,2007,4(5):337-339. 15 程祝忠,李迎春,许国辉,等.动脉介入栓塞剂在儿童头颈部血管瘤栓塞治疗的表现及介入治疗中的意义[J].中华妇幼临床医学杂志,2008,4(5):48-51. 16 Müller H,Guadagni S.Regional chemotherapy for carcinoma of the lung[J].Surg Oncol Clin North America,2008,17(4):895-917. 17 朱红霞,刘爽,周翠绮,等.抗凋亡基因Survivin促进细胞转化的作用机制[J].中华医学杂志,2002,82(5):338-340. 18 Kawai S,Suzuki K,Nishio K,et a1.Smoking and serum CA199 levels according to Lewis and secretor genotypes[J].Int J Cancer,2008,123(12):2880-2884. 19 Jia ZL,Zhang HY,Liu C,et a1.Serum tumor markers combined detection applied in the diagnosis of pancreatic cancer[J].Chin Pract Diag Ther,2011,25:130-131. 20 展超,金宇,张玉宝,等.早中期胰腺癌患者血清特异性糖链与CA19-9、CEA检测比较的研究[J].实用肿瘤学杂志,2015,29(1):7-11. 21 赵琳,曹梦晗,王民宪.血清TK1监测对胰腺癌诊断的临床意义[J].中国实验诊断学,2014,11(8):1773-1775. |